NYSE:CTST - CannTrust Stock Price, News, & Analysis

CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."

CannTrust Holdings Inc (NYSE:CTST) announced its earnings results on Tuesday, May, 14th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of ($0.05) by $0.14. The business earned $16.85 million during the quarter, compared to analysts' expectations of $17 million. CannTrust had a negative return on equity of 6.69% and a negative net margin of 22.33%. The business's revenue was up 114.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.12 earnings per share. View CannTrust's Earnings History.

CannTrust is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for CannTrust.

CannTrust updated its first quarter 2019 earnings guidance on Monday, April, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $17-17 million.

2 brokers have issued twelve-month target prices for CannTrust's shares. Their forecasts range from C$5.69 to C$14.50. On average, they anticipate CannTrust's stock price to reach C$10.10 in the next twelve months. This suggests a possible upside of 73.9% from the stock's current price. View Analyst Price Targets for CannTrust.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CannTrust.

News headlines about CTST stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CannTrust earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.

CannTrust saw a increase in short interest in April. As of April 15th, there was short interest totalling 3,363,856 shares, an increase of 41.7% from the March 29th total of 2,374,612 shares. Based on an average trading volume of 1,834,704 shares, the short-interest ratio is currently 1.8 days. View CannTrust's Current Options Chain.

Some companies that are related to CannTrust include Amneal Pharmaceuticals (AMRX), Uniqure (QURE), PTC Therapeutics (PTCT), Myokardia (MYOK), Emergent Biosolutions (EBS), Ligand Pharmaceuticals (LGND), Arrowhead Pharmaceuticals (ARWR), Insmed (INSM), AnaptysBio (ANAB), Portola Pharmaceuticals (PTLA), Akcea Therapeutics (AKCA), Endocyte (ECYT), Allakos (ALLK), Tricida (TCDA) and Xencor (XNCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), KushCo (KSHB), Aurora Cannabis (ACB), Aphria (APHA), Cronos Group (CRON), Canopy Growth (WEED), Aphria (APHA), Surna (SRNA) and OrganiGram (OGRMF).

CannTrust's stock is owned by many different of institutional and retail investors. Top institutional investors include The Manufacturers Life Insurance Company (1.45%), JW Asset Management LLC (1.33%), Morgan Stanley (1.02%), Davis Rea LTD. (0.47%), Toronto Dominion Bank (0.25%) and Legacy Advisors LLC (0.19%). Company insiders that own CannTrust stock include Aubrey Dan, Financial Corporation Forum, Mark Litwin and Mitchell J Sanders. View Institutional Ownership Trends for CannTrust.

CTST stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , JW Asset Management LLC, Morgan Stanley, Davis Rea LTD., Toronto Dominion Bank, Legacy Advisors LLC, CIBC Asset Management Inc and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. View Insider Buying and Selling for CannTrust.

Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CTST stock can currently be purchased for approximately C$5.81.

CannTrust has a market capitalization of C$613.33 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe.

The official website for CannTrust is http://canntrust.ca/.

CannTrust's mailing address is 3280 Langstaff Road Building 1, Vaughan A6, L4K 5B6. The company can be reached via phone at 64-7872-2300 or via email at [email protected]